|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 38/19 | |
| A61K 45/06 | |||
| A61P 35/00 | |||
| A61P 35/04 | |||
| A61K 49/04 | |||
| A61K 49/08 |
| (11) | Patento numeris | 2509618 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 10793288.1 |
| Europos patento paraiškos padavimo data | 2010-12-08 | |
| (97) | Europos patento paraiškos paskelbimo data | 2012-10-17 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2017-08-30 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/GB2010/052048 |
| Data | 2010-12-08 |
| (87) | Numeris | WO 2011/070358 |
| Data | 2011-06-16 |
| (30) | Numeris | Data | Šalis |
| 0921525 | 2009-12-08 | GB |
| (72) |
ANTHONY, Daniel, GB
SIBSON, Nicola, GB
SEYMOUR, Len, GB
FISHER, Kerry, GB
|
| (73) |
Oxford University Innovation Limited,
Buxton Court 3 West Way, Botley Oxford OX2 0JB,
GB
|
| (54) | Systemic administration of an agent that permeabilises tumour vasculature |
| Systemic administration of an agent that permeabilises tumour vasculature |